Lymphoma is a group of malignant diseases originating from lymph nodes and extra-lymph node tissues. It is a malignant tumor of the immune system and has a mortality rate of 1.5 per 100,000 in China. The mortality rate of lymphoma in China is 1.5 per 100,000. It ranks eleventh to thirteenth in terms of malignant lymphoma deaths. The incidence rate in urban areas is higher than that in rural areas. Malignant lymphoma is mainly in China, although relatively rare, the incidence rate is relatively high this year and can exceed 25,000 cases per year, while in Western countries such as Europe, America and Australia, the incidence rate can be as high as 11 to 18 per 100,000, slightly higher than the total of all types of leukemia, while in the United States there are at least 30,000 new cases per year, and in response to this situation, for The attack of lymphoma has been studied, and at present, the main treatment is a combination of chemotherapy regimens.